S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in
NASDAQ:AUTL

Autolus Therapeutics Short Interest Ratio and Short Volume

$6.86
+0.42 (+6.52 %)
(As of 03/1/2021 05:23 PM ET)
Add
Compare
Today's Range
$6.55
Now: $6.86
$6.94
50-Day Range
$6.54
MA: $8.02
$9.28
52-Week Range
$3.00
Now: $6.86
$17.19
Volume691,598 shs
Average Volume912,338 shs
Market Capitalization$358.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.75

Short Interest

Autolus Therapeutics (NASDAQ:AUTL) Short Interest Data

Current Short Volume1,710,000 shares
Previous Short Volume743,600 shares
Change Vs. Previous Month:+129.96%
Dollar Volume Sold Short$11.01 million
Short Interest Ratio / Days to Cover3.0
Last Record DateFebruary, 12 2021
Outstanding Shares44,980,000 shares
Percentage of Shares Shorted3.27%
Today's Trading Volume691,598 shares
Average Trading Volume912,338 shares
Today's Volume Vs. Average-24.19%

Short Interest Over Time


Autolus Therapeutics (NASDAQ:AUTL) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/20211,710,000 shares $11.01 million +130.0%N/A3 $6.44
1/29/2021743,600 shares $5.21 million +5.4%N/A3.7 $7.00
1/15/2021705,300 shares $5.39 million -0.1%N/A4 $7.64
12/31/2020861,500 shares $7.55 million +8.2%N/A8.2 $8.76
12/15/2020861,500 shares $7.99 million +8.2%N/A8.2 $9.27
11/30/2020796,000 shares $6.86 million +5.2%N/A9.7 $8.62
11/15/2020756,400 shares $7.93 million -2.3%N/A10.4 $10.49
10/30/2020774,200 shares $8.49 million +12.9%N/A9.6 $10.97
10/15/2020686,000 shares $7.67 million -5.9%N/A6.2 $11.18
9/30/2020729,300 shares $9.26 million +13.5%N/A4.9 $12.70
9/15/2020642,500 shares $8.20 million -15.9%N/A3.9 $12.77
8/31/2020763,900 shares $9.98 million +4.8%N/A3.7 $13.07
8/14/2020728,800 shares $10.24 million +12.1%N/A3.3 $14.05
7/31/2020650,200 shares $10.43 million +24.1%N/A3 $16.04
7/15/2020523,800 shares $6.91 million +0.3%N/A2.7 $13.20
6/30/2020522,200 shares $7.27 million -38.6%N/A3 $13.93
6/15/2020850,100 shares $13.62 million +24.2%N/A4.8 $16.02
5/29/2020684,700 shares $10.73 million -13.7%N/A4.6 $15.67
5/15/2020793,500 shares $9.93 million +20.6%N/A5.5 $12.52
4/30/2020657,900 shares $7.97 million -3.6%N/A4.4 $12.11
4/15/2020682,300 shares $7.18 million +15.1%N/A3.4 $10.52
3/31/2020593,000 shares $6.07 million -5.9%N/A3.1 $10.24
3/13/2020630,400 shares $5.04 million -25.3%N/A3.7 $7.99
2/28/2020844,300 shares $3.74 million +6.0%N/A4.4 $4.43
2/14/2020796,800 shares $5.77 million -38.2%1.8%4.4 $7.24

Autolus Therapeutics (NASDAQ:AUTL) Short Interest FAQ

speech bubbles
speech bubbles











What is Autolus Therapeutics' current short interest?

Short interest is the volume of Autolus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 12th, investors have sold 1,710,000 shares of AUTL short.

What is a good short interest ratio for Autolus Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Autolus Therapeutics currently has a short interest ratio of 3.0.

Is Autolus Therapeutics' short interest increasing or decreasing?

Autolus Therapeutics saw a increase in short interest in February. As of February 12th, there was short interest totaling 1,710,000 shares, an increase of 130.0% from the previous total of 743,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Autolus Therapeutics' short interest compare to its competitors?

0.00% of Autolus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Autolus Therapeutics: Atara Biotherapeutics, Inc. (0.00%), Adverum Biotechnologies, Inc. (0.00%), Vaxcyte, Inc. (12.06%), Coherus BioSciences, Inc. (19.38%), Mesoblast Limited (0.00%), Aligos Therapeutics, Inc. (6.61%), Taysha Gene Therapies, Inc. (6.91%), Black Diamond Therapeutics, Inc. (12.98%), Cortexyme, Inc. (17.65%), and Inhibrx, Inc. (2.72%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Autolus Therapeutics stock?

Short selling AUTL is an investing strategy that aims to generate trading profit from Autolus Therapeutics as its price is falling. Autolus Therapeutics' stock is trading up $0.42 today. To short Autolus Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Autolus Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Autolus Therapeutics?

A short squeeze for Autolus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AUTL, which in turn drives the price of the stock up even further.

How often is Autolus Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AUTL, twice per month. The most recent reporting period available is February, 12 2021.



This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.